down arrow

Dr Reddy's Labs

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE089A01031
  • NSEID: DRREDDY
  • BSEID: 500124
INR
1,123.45
28.3 (2.58%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 12.88 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationUpcoming Result: Dr Reddy's Labs will declare its result soon on 09 May 2025
stock-summaryPrice Point
High/Low

1Day

1,111.501,142.90

52 Week

1,025.901,420.20
Valuation
Technical
Day's Volume

CASH

12.88 lacs (-57.02%) Volume

Shareholding (Dec 2024)

FII

26.85%

Held by 828 FIIs

DII

36.13%

Held by 93 DIIs

Promoter

26.64%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Flat results in Dec 24

  • NO KEY NEGATIVE TRIGGERS
2

Stock is technically in a Bearish range

3

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 93,747 Cr (Large Cap)

stock-summary
P/E

17.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.73%

stock-summary
Debt Equity

-0.01

stock-summary
Return on Equity

17.36%

stock-summary
Price to Book

2.97

Revenue and Profits (1 Year):
Net Sales:
8,381 Cr
(Quarterly Results - Dec 2024)
Net Profit:
1,414 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.73%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-14.98%
0%
-14.98%
1 Year
-8.8%
3.18%
-5.62%
2 Years
17.86%
8.15%
26.01%
3 Years
28.25%
14.19%
42.44%
4 Years
18.02%
12.85%
30.87%
5 Years
55.25%
20.54%
75.79%

Latest dividend: 40 per share ex-dividend date: Jul-16-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
12.84%
EBIT Growth (5y)
42.00%
EBIT to Interest (avg)
31.51
Debt to EBITDA (avg)
0.58
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.95
Tax Ratio
25.16%
Dividend Payout Ratio
11.96%
Pledged Shares
0
Institutional Holding
62.98%
ROCE (avg)
18.52%
ROE (avg)
14.51%
Valuation key factors
Factor
Value
P/E Ratio
17
Industry P/E
33
Price to Book Value
2.97
EV to EBIT
13.62
EV to EBITDA
10.97
EV to Capital Employed
2.99
EV to Sales
2.92
PEG Ratio
6.32
Dividend Yield
0.73%
ROCE (Latest)
21.44%
ROE (Latest)
17.36%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

FIIs

Pledged Promoter Holdings

None

Mutual Funds

Held by 37 Schemes (11.14%)

FIIs

Held by 828 FIIs (26.85%)

Promoter with highest holding

G V Prasad (11.52%)

Highest Public shareholder

J P Morgan Chase Bank Na (13.23%)

Individual Investors Holdings

8.07%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 4.27% vs 4.45% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 12.58% vs -9.82% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8,381.20",
          "val2": "8,038.20",
          "chgp": "4.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,273.00",
          "val2": "2,076.50",
          "chgp": "9.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "81.70",
          "val2": "75.70",
          "chgp": "7.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,413.70",
          "val2": "1,255.70",
          "chgp": "12.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "27.19%",
          "val2": "25.90%",
          "chgp": "1.29%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 15.18% vs 18.12% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -8.28% vs 25.36% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "15,734.30",
          "val2": "13,660.50",
          "chgp": "15.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4,226.40",
          "val2": "4,070.40",
          "chgp": "3.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "135.50",
          "val2": "72.40",
          "chgp": "87.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,648.10",
          "val2": "2,887.20",
          "chgp": "-8.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.94%",
          "val2": "29.89%",
          "chgp": "-2.95%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 15.40% vs 13.85% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -4.83% vs 20.33% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "24,115.50",
          "val2": "20,897.30",
          "chgp": "15.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "6,499.40",
          "val2": "6,093.50",
          "chgp": "6.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "217.20",
          "val2": "111.80",
          "chgp": "94.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4,061.80",
          "val2": "4,268.10",
          "chgp": "-4.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.95%",
          "val2": "29.16%",
          "chgp": "-2.21%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 13.54% vs 14.50% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 23.75% vs 106.52% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "28,011.10",
          "val2": "24,669.70",
          "chgp": "13.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7,933.10",
          "val2": "6,349.00",
          "chgp": "24.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "171.10",
          "val2": "142.80",
          "chgp": "19.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5,577.90",
          "val2": "4,507.30",
          "chgp": "23.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "28.42%",
          "val2": "25.82%",
          "chgp": "2.60%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
8,381.20
8,038.20
4.27%
Operating Profit (PBDIT) excl Other Income
2,273.00
2,076.50
9.46%
Interest
81.70
75.70
7.93%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1,413.70
1,255.70
12.58%
Operating Profit Margin (Excl OI)
27.19%
25.90%
1.29%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 4.27% vs 4.45% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 12.58% vs -9.82% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
15,734.30
13,660.50
15.18%
Operating Profit (PBDIT) excl Other Income
4,226.40
4,070.40
3.83%
Interest
135.50
72.40
87.15%
Exceptional Items
0.00
0.00
Consolidate Net Profit
2,648.10
2,887.20
-8.28%
Operating Profit Margin (Excl OI)
26.94%
29.89%
-2.95%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 15.18% vs 18.12% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is -8.28% vs 25.36% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
24,115.50
20,897.30
15.40%
Operating Profit (PBDIT) excl Other Income
6,499.40
6,093.50
6.66%
Interest
217.20
111.80
94.28%
Exceptional Items
0.00
0.00
Consolidate Net Profit
4,061.80
4,268.10
-4.83%
Operating Profit Margin (Excl OI)
26.95%
29.16%
-2.21%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 15.40% vs 13.85% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -4.83% vs 20.33% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
28,011.10
24,669.70
13.54%
Operating Profit (PBDIT) excl Other Income
7,933.10
6,349.00
24.95%
Interest
171.10
142.80
19.82%
Exceptional Items
0.00
0.00
Consolidate Net Profit
5,577.90
4,507.30
23.75%
Operating Profit Margin (Excl OI)
28.42%
25.82%
2.60%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 13.54% vs 14.50% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 23.75% vs 106.52% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Dr Reddys Laboratories Ltd stock-summary
stock-summary
Dr Reddys Laboratories Ltd
Large Cap
Pharmaceuticals & Drugs
Dr Reddy's Laboratories Limited (DRL) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services &Active Ingredients, Global Generics and Proprietary Products - Dr. Reddy's offers a portfolio of products and services including Active Pharmaceutical Ingredients (APIs), custom pharmaceutical services, generics, biosimilars and differentiated formulations.
Company Coordinates stock-summary
Company Details
8-2-337 Road No 3, Banjara Hills Hyderabad Telangana : 500034
stock-summary
Tel: 91-40-49002900
stock-summary
http://www.drreddys.com
stock-summary
shares@drreddys.com
Registrar Details
Bigshare Services Pvt Ltd , 306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital, Raj Bhavan Road, Somajiguda, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."